25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PNVL3 (Dimed) Stock Analysis
Buy, Hold or Sell?

Let's analyze Dimed together

I guess you are interested in Dimed S.A. Distribuidora de Medicamentos. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Dimed’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Dimed’s Price Targets

I'm going to help you getting a better view of Dimed S.A. Distribuidora de Medicamentos. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Dimed S.A. Distribuidora de Medicamentos

I send you an email if I find something interesting about Dimed S.A. Distribuidora de Medicamentos.

1. Quick Overview

1.1. Quick analysis of Dimed (30 sec.)










1.2. What can you expect buying and holding a share of Dimed? (30 sec.)

How much money do you get?

How much money do you get?
R$0.04
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
R$8.36
Expected worth in 1 year
R$8.69
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
R$0.53
Return On Investment
5.6%

For what price can you sell your share?

Current Price per Share
R$9.54
Expected price per share
R$8.9844 - R$10.35
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Dimed (5 min.)




Live pricePrice per Share (EOD)
R$9.54
Intrinsic Value Per Share
R$10.19 - R$61.33
Total Value Per Share
R$18.55 - R$69.69

2.2. Growth of Dimed (5 min.)




Is Dimed growing?

Current yearPrevious yearGrowGrow %
How rich?$229.7m$213.6m$9.7m4.4%

How much money is Dimed making?

Current yearPrevious yearGrowGrow %
Making money$4.4m$4.9m-$498.5k-11.1%
Net Profit Margin1.9%2.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Dimed (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Dimed?

Welcome investor! Dimed's management wants to use your money to grow the business. In return you get a share of Dimed.

First you should know what it really means to hold a share of Dimed. And how you can make/lose money.

Speculation

The Price per Share of Dimed is R$9.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dimed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dimed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is R$8.36. Based on the TTM, the Book Value Change Per Share is R$0.08 per quarter. Based on the YOY, the Book Value Change Per Share is R$0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is R$0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dimed.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 R$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per Share
Usd Eps0.030.3%0.030.3%0.030.4%0.030.3%0.030.3%0.020.2%
Usd Book Value Change Per Share0.010.1%0.020.2%0.030.3%0.020.2%0.040.5%0.030.3%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.020.2%0.020.3%0.040.4%0.030.3%0.050.5%0.040.4%
Usd Price Per Share1.60-1.72-2.30-1.97-2.63-37.68-
Price to Earnings Ratio12.65-26.03-17.69-20.87-43.97-499.01-
Price-to-Total Gains Ratio68.38-8.81-64.43--10.64--1.69-1,990.18-
Price to Book Ratio1.03-1.15-1.61-1.39-2.28-72.08-
Price-to-Total Gains Ratio68.38-8.81-64.43--10.64--1.69-1,990.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.759176
Number of shares568
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.04
Usd Total Gains Per Share0.020.05
Gains per Quarter (568 shares)13.9229.75
Gains per Year (568 shares)55.67119.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
121344619100109
2426910238200228
36410315857300347
48513821476400466
510617227095500585
6127207326114600704
7149241382133700823
8170276438152800942
91913104941719001061
1021234455019010001180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%70.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%34.06.00.085.0%59.06.05.084.3%
Dividend per Share3.00.01.075.0%11.00.01.091.7%19.00.01.095.0%39.00.01.097.5%63.00.07.090.0%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%15.05.00.075.0%35.05.00.087.5%62.05.03.088.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Dimed S.A. Distribuidora de Medicamentos compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0750.082-9%0.152-51%0.100-25%0.239-69%0.156-52%
Book Value Per Share--8.3618.123+3%7.766+8%7.736+8%7.124+17%4.977+68%
Current Ratio--1.9011.694+12%1.603+19%1.656+15%1.746+9%1.719+11%
Debt To Asset Ratio--0.6080.625-3%0.614-1%0.6080%0.589+3%0.569+7%
Debt To Equity Ratio--1.5491.669-7%1.590-3%1.5560%1.452+7%1.355+14%
Dividend Per Share--0.0520.051+2%0.053-3%0.050+3%0.045+15%0.037+39%
Enterprise Value---640295980.800-462042268.740-28%260996921.740-345%-10222611.175-98%861918569.889-174%29562476418.761-102%
Eps--0.1710.163+5%0.181-6%0.161+6%0.142+20%0.125+37%
Ev To Sales Ratio---0.127-0.091-28%0.057-322%0.003-5115%0.297-143%12.691-101%
Free Cash Flow Per Share--0.4560.240+90%0.298+53%0.218+110%0.122+275%0.100+354%
Free Cash Flow To Equity Per Share--0.4560.013+3460%-0.041+109%0.063+628%0.034+1241%0.041+1013%
Gross Profit Margin--1.000-15.911+1691%-9.622+1062%-10.687+1169%-10.737+1174%-8.336+934%
Intrinsic Value_10Y_max--61.332----------
Intrinsic Value_10Y_min--10.192----------
Intrinsic Value_1Y_max--1.636----------
Intrinsic Value_1Y_min--0.510----------
Intrinsic Value_3Y_max--8.353----------
Intrinsic Value_3Y_min--1.985----------
Intrinsic Value_5Y_max--19.213----------
Intrinsic Value_5Y_min--3.943----------
Market Cap1421488696.320+9%1288876019.2001387980481.260-7%1863525421.740-31%1599965805.492-19%2209096469.889-42%30491964493.761-96%
Net Profit Margin--0.0200.019+5%0.023-12%0.021-3%0.021-5%0.024-16%
Operating Margin---0.034-100%0.045-100%0.040-100%0.038-100%0.040-100%
Operating Ratio--1.6391.131+45%0.954+72%1.017+61%0.998+64%0.972+69%
Pb Ratio1.141+9%1.0351.148-10%1.609-36%1.388-25%2.283-55%72.078-99%
Pe Ratio13.955+9%12.65326.033-51%17.688-28%20.870-39%43.974-71%499.008-97%
Price Per Share9.540+9%8.6509.303-7%12.488-31%10.691-19%14.264-39%204.359-96%
Price To Free Cash Flow Ratio5.226+9%4.7381.447+227%-6.940+246%-2.549+154%0.170+2681%-1261.455+26724%
Price To Total Gains Ratio75.419+9%68.3838.807+676%64.429+6%-10.641+116%-1.690+102%1990.178-97%
Quick Ratio--0.6030.753-20%0.890-32%0.829-27%0.934-35%0.791-24%
Return On Assets--0.0080.007+7%0.009-10%0.008-1%0.0080%0.013-36%
Return On Equity--0.0200.020+2%0.023-12%0.021-2%0.020+5%0.029-29%
Total Gains Per Share--0.1260.133-5%0.206-38%0.151-16%0.284-55%0.193-34%
Usd Book Value--229730130.000223478278.500+3%213680092.300+8%213418290.400+8%199296883.080+15%138529329.060+66%
Usd Book Value Change Per Share--0.0140.015-9%0.028-51%0.018-25%0.044-69%0.029-52%
Usd Book Value Per Share--1.5421.498+3%1.432+8%1.426+8%1.314+17%0.918+68%
Usd Dividend Per Share--0.0100.009+2%0.010-3%0.009+3%0.008+15%0.007+39%
Usd Enterprise Value---118070578.860-85200594.356-28%48127832.369-345%-1885049.501-98%158937784.288-174%5451320651.619-102%
Usd Eps--0.0320.030+5%0.033-6%0.030+6%0.026+20%0.023+37%
Usd Free Cash Flow--12540490.8006605392.400+90%8220367.600+53%6001820.467+109%3368250.400+272%2773938.420+352%
Usd Free Cash Flow Per Share--0.0840.044+90%0.055+53%0.040+110%0.022+275%0.019+354%
Usd Free Cash Flow To Equity Per Share--0.0840.002+3460%-0.008+109%0.012+628%0.006+1241%0.008+1013%
Usd Market Cap262122515.601+9%237668737.940255943600.744-7%343634087.769-31%295033694.533-19%407357389.048-42%5622718252.649-96%
Usd Price Per Share1.759+9%1.5951.715-7%2.303-31%1.971-19%2.630-39%37.684-96%
Usd Profit--4695930.4004491292.500+5%4989817.900-6%4450447.900+6%3976438.480+18%3458076.250+36%
Usd Revenue--232102067.200229349666.700+1%214812584.900+8%211308447.067+10%184438687.120+26%146390061.340+59%
Usd Total Gains Per Share--0.0230.025-5%0.038-38%0.028-16%0.052-55%0.036-34%
 EOD+4 -4MRQTTM+25 -14YOY+17 -223Y+22 -175Y+21 -1810Y+19 -20

3.3 Fundamental Score

Let's check the fundamental score of Dimed S.A. Distribuidora de Medicamentos based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.955
Price to Book Ratio (EOD)Between0-11.141
Net Profit Margin (MRQ)Greater than00.020
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.603
Current Ratio (MRQ)Greater than11.901
Debt to Asset Ratio (MRQ)Less than10.608
Debt to Equity Ratio (MRQ)Less than11.549
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.008
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Dimed S.A. Distribuidora de Medicamentos based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.521
Ma 20Greater thanMa 508.944
Ma 50Greater thanMa 1008.919
Ma 100Greater thanMa 2008.646
OpenGreater thanClose9.600
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Dimed S.A. Distribuidora de Medicamentos

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermo-cosmetics in Brazil. The company operates in Retail and Wholesale segments. It offers its products through distribution centers in the states of Rio Grande do Sul, ParanΓ‘, and EspΓ­rito Santo. The company operates through its stores in Rio Grande do Sul, Santa Catarina, ParanΓ‘, and SΓ£o Paulo. It offers its products under Panvel brand. In addition, the company owns, manages, and sells properties. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.

Fundamental data was last updated by Penke on 2025-07-02 05:03:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Dimed earns for each R$1 of revenue.

  • Above 10% is considered healthy but always compareΒ Dimed to theΒ Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 2.0%Β means thatΒ R$0.02 for each R$1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 2.0%. The company is making a profit. +1
  • The TTM is 1.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM1.9%+0.1%
TTM1.9%YOY2.3%-0.4%
TTM1.9%5Y2.1%-0.2%
5Y2.1%10Y2.4%-0.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Dimed is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Dimed to theΒ Drug Manufacturers - General industry mean.
  • 0.8% Return on Assets means thatΒ Dimed generatedΒ R$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.7%+0.1%
TTM0.7%YOY0.9%-0.1%
TTM0.7%5Y0.8%-0.1%
5Y0.8%10Y1.3%-0.4%
4.3.1.3. Return on Equity

Shows how efficient Dimed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Dimed to theΒ Drug Manufacturers - General industry mean.
  • 2.0% Return on Equity means Dimed generated R$0.02Β for eachΒ R$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%+0.0%
TTM2.0%YOY2.3%-0.3%
TTM2.0%5Y2.0%+0.0%
5Y2.0%10Y2.9%-0.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Dimed S.A. Distribuidora de Medicamentos.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Dimed is operatingΒ .

  • Measures how much profit Dimed makes for each R$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Dimed to theΒ Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0%Β means the company generated R$0.00 Β for each R$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.4%-3.4%
TTM3.4%YOY4.5%-1.1%
TTM3.4%5Y3.8%-0.4%
5Y3.8%10Y4.0%-0.2%
4.3.2.2. Operating Ratio

Measures how efficient Dimed is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.64 means that the operating costs are R$1.64 for each R$1 in net sales.

Let's take a look of the Operating Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 1.639. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.131. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.639TTM1.131+0.508
TTM1.131YOY0.954+0.177
TTM1.1315Y0.998+0.133
5Y0.99810Y0.972+0.027
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Dimed S.A. Distribuidora de Medicamentos.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Dimed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.90Β means the company has R$1.90 in assets for each R$1 in short-term debts.

Let's take a look of the Current Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 1.901. The company is able to pay all its short-term debts. +1
  • The TTM is 1.694. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.901TTM1.694+0.207
TTM1.694YOY1.603+0.091
TTM1.6945Y1.746-0.051
5Y1.74610Y1.719+0.027
4.4.3.2. Quick Ratio

Measures if Dimed is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Dimed to theΒ Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.60Β means the company can pay off R$0.60 for each R$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 0.603. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.753. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.603TTM0.753-0.149
TTM0.753YOY0.890-0.138
TTM0.7535Y0.934-0.182
5Y0.93410Y0.791+0.143
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Dimed S.A. Distribuidora de Medicamentos.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of DimedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Dimed to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.61Β means that Dimed assets areΒ financed with 60.8% credit (debt) and the remaining percentage (100% - 60.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 0.608. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.625. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.608TTM0.625-0.017
TTM0.625YOY0.614+0.011
TTM0.6255Y0.589+0.036
5Y0.58910Y0.569+0.019
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Dimed is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Dimed to theΒ Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 154.9% means that company has R$1.55 debt for each R$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 1.549. The company is just able to pay all its debts with equity.
  • The TTM is 1.669. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.549TTM1.669-0.120
TTM1.669YOY1.590+0.079
TTM1.6695Y1.452+0.216
5Y1.45210Y1.355+0.098
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every R$1 in earnings Dimed generates.

  • Above 15 is considered overpriced butΒ always compareΒ Dimed to theΒ Drug Manufacturers - General industry mean.
  • A PE ratio of 12.65 means the investor is paying R$12.65Β for every R$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The EOD is 13.955. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.653. Based on the earnings, the company is underpriced. +1
  • The TTM is 26.033. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.955MRQ12.653+1.302
MRQ12.653TTM26.033-13.380
TTM26.033YOY17.688+8.345
TTM26.0335Y43.974-17.941
5Y43.97410Y499.008-455.034
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The EOD is 5.226. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.738. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.447. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.226MRQ4.738+0.487
MRQ4.738TTM1.447+3.291
TTM1.447YOY-6.940+8.388
TTM1.4475Y0.170+1.277
5Y0.17010Y-1,261.455+1,261.626
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Dimed is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.03 means the investor is paying R$1.03Β for each R$1 in book value.

Let's take a look of the Price to Book Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The EOD is 1.141. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.035. Based on the equity, the company is underpriced. +1
  • The TTM is 1.148. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.141MRQ1.035+0.106
MRQ1.035TTM1.148-0.113
TTM1.148YOY1.609-0.461
TTM1.1485Y2.283-1.135
5Y2.28310Y72.078-69.795
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in BRL. All numbers in thousands.

Summary
Total Assets3,174,997
Total Liabilities1,929,172
Total Stockholder Equity1,245,825
 As reported
Total Liabilities 1,929,172
Total Stockholder Equity+ 1,245,825
Total Assets = 3,174,997

Assets

Total Assets3,174,997
Total Current Assets1,788,283
Long-term Assets1,386,714
Total Current Assets
Cash And Cash Equivalents 88,226
Short-term Investments 116,124
Net Receivables 451,617
Inventory 958,242
Total Current Assets  (as reported)1,788,283
Total Current Assets  (calculated)1,614,209
+/- 174,074
Long-term Assets
Property Plant Equipment 1,193,866
Goodwill 5,956
Intangible Assets 92,539
Long-term Assets Other 208
Long-term Assets  (as reported)1,386,714
Long-term Assets  (calculated)1,292,569
+/- 94,145

Liabilities & Shareholders' Equity

Total Current Liabilities940,753
Long-term Liabilities988,419
Total Stockholder Equity1,245,825
Total Current Liabilities
Short Long Term Debt 130,233
Accounts payable 456,778
Other Current Liabilities 65,801
Total Current Liabilities  (as reported)940,753
Total Current Liabilities  (calculated)652,812
+/- 287,941
Long-term Liabilities
Long term Debt 397,074
Capital Lease Obligations Min Short Term Debt695,313
Long-term Liabilities Other 7,694
Long-term Liabilities  (as reported)988,419
Long-term Liabilities  (calculated)1,100,081
+/- 111,662
Total Stockholder Equity
Retained Earnings 12,586
Total Stockholder Equity (as reported)1,245,825
Total Stockholder Equity (calculated)12,586
+/- 1,233,239
Other
Capital Stock981,773
Common Stock Shares Outstanding 148,793
Net Debt 439,081
Net Invested Capital 1,773,132
Net Working Capital 847,530
Property Plant and Equipment Gross 2,190,550



6.2. Balance Sheets Structured

Currency in BRL. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-03-312008-12-312007-12-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-03-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
147,793
156,506
145,207
172,018
180,584
0
217,513
217,513
0
199,616
234,294
234,294
253,461
275,749
0
333,081
311,863
315,475
347,161
377,105
360,463
378,554
393,614
442,155
434,869
437,263
457,018
500,654
512,711
527,245
579,734
599,894
574,097
636,431
669,903
719,271
677,438
704,124
709,386
759,967
741,417
779,003
756,970
820,973
775,896
820,240
829,558
950,172
885,296
921,353
954,818
1,000,375
1,206,297
1,285,724
1,352,517
1,460,285
1,588,261
1,537,852
2,176,369
2,194,373
2,253,459
2,141,926
2,253,832
2,381,060
2,482,438
2,504,634
2,569,515
2,733,126
2,816,567
2,783,735
2,945,705
3,077,470
3,204,298
3,147,471
3,232,719
3,377,453
3,174,997
3,174,9973,377,4533,232,7193,147,4713,204,2983,077,4702,945,7052,783,7352,816,5672,733,1262,569,5152,504,6342,482,4382,381,0602,253,8322,141,9262,253,4592,194,3732,176,3691,537,8521,588,2611,460,2851,352,5171,285,7241,206,2971,000,375954,818921,353885,296950,172829,558820,240775,896820,973756,970779,003741,417759,967709,386704,124677,438719,271669,903636,431574,097599,894579,734527,245512,711500,654457,018437,263434,869442,155393,614378,554360,463377,105347,161315,475311,863333,0810275,749253,461234,294234,294199,6160217,513217,5130180,584172,018145,207156,506147,793
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
401,204
403,259
401,525
426,460
421,167
382,255
437,704
466,652
508,347
462,777
487,394
491,407
539,884
519,855
559,936
531,056
590,440
540,856
582,495
586,174
705,024
633,663
659,507
685,382
727,126
702,804
770,640
813,547
851,138
963,573
858,033
1,436,985
1,376,502
1,436,131
1,247,790
1,314,467
1,395,084
1,436,783
1,411,566
1,432,112
1,558,547
1,622,645
1,585,439
1,735,157
1,840,064
1,948,367
1,887,477
1,921,768
2,012,581
1,788,283
1,788,2832,012,5811,921,7681,887,4771,948,3671,840,0641,735,1571,585,4391,622,6451,558,5471,432,1121,411,5661,436,7831,395,0841,314,4671,247,7901,436,1311,376,5021,436,985858,033963,573851,138813,547770,640702,804727,126685,382659,507633,663705,024586,174582,495540,856590,440531,056559,936519,855539,884491,407487,394462,777508,347466,652437,704382,255421,167426,460401,525403,259401,204000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,159
19,476
8,236
24,455
7,613
4,871
4,281
4,834
7,503
4,113
5,031
4,128
17,002
11,750
31,351
9,937
22,340
17,772
5,292
9,781
58,792
11,742
14,781
10,697
39,141
12,225
56,607
66,521
71,437
140,683
79,872
514,334
130,107
43,071
47,351
18,672
54,435
43,319
41,561
22,862
25,715
14,367
12,272
15,578
27,953
22,126
16,700
12,175
79,995
88,226
88,22679,99512,17516,70022,12627,95315,57812,27214,36725,71522,86241,56143,31954,43518,67247,35143,071130,107514,33479,872140,68371,43766,52156,60712,22539,14110,69714,78111,74258,7929,7815,29217,77222,3409,93731,35111,75017,0024,1285,0314,1137,5034,8344,2814,8717,61324,4558,23619,4769,159000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,086
0
0
0
11,279
7,774
2,881
8,863
17,263
9,552
7,457
8,168
0
-9,176
-9,775
-10,189
-10,791
-11,073
-10,630
-11,135
-11,515
-10,943
-10,954
-11,340
-10,733
-10,005
-10,577
-11,708
-10,152
-10,235
-10,158
65,457
305,701
250,877
124,809
186,855
155,216
52,614
85,409
141,388
131,640
243,280
180,937
249,453
217,436
240,196
253,891
188,690
133,413
116,124
116,124133,413188,690253,891240,196217,436249,453180,937243,280131,640141,38885,40952,614155,216186,855124,809250,877305,70165,457-10,158-10,235-10,152-11,708-10,577-10,005-10,733-11,340-10,954-10,943-11,515-11,135-10,630-11,073-10,791-10,189-9,775-9,17608,1687,4579,55217,2638,8632,8817,77411,27900019,086000000000000000000000000000
       Net Receivables 
39,011
37,900
42,633
47,910
55,062
0
78,434
78,434
0
74,398
77,817
77,817
81,376
85,726
0
89,682
92,608
111,419
110,865
116,059
112,071
129,710
127,716
132,816
139,722
151,749
163,105
155,405
147,860
133,809
163,889
145,513
122,432
161,545
161,785
185,104
177,767
181,423
181,520
208,784
192,972
216,294
187,675
199,902
170,702
193,345
182,290
233,200
216,318
220,178
234,429
240,429
241,471
278,180
296,208
343,123
320,690
318,066
327,820
351,565
349,812
344,337
365,012
399,456
426,707
420,065
422,918
464,731
452,569
447,824
505,184
560,353
574,737
519,123
515,845
578,004
451,617
451,617578,004515,845519,123574,737560,353505,184447,824452,569464,731422,918420,065426,707399,456365,012344,337349,812351,565327,820318,066320,690343,123296,208278,180241,471240,429234,429220,178216,318233,200182,290193,345170,702199,902187,675216,294192,972208,784181,520181,423177,767185,104161,785161,545122,432145,513163,889133,809147,860155,405163,105151,749139,722132,816127,716129,710112,071116,059110,865111,41992,60889,682085,72681,37677,81777,81774,398078,43478,434055,06247,91042,63337,90039,011
       Other Current Assets 
2,413
2,682
2,032
2,345
2,057
0
3,652
3,652
0
3,709
3,125
3,125
4,698
6,663
0
6,219
8,831
715
9,089
191
0
0
191
191
191
191
191
7,195
25,535
25,101
18,868
8,333
19,493
27,172
21,193
26,902
12,396
12,368
16,890
6,258
7,458
15,045
18,918
11,161
10,609
20,661
24,451
14,356
15,913
23,452
30,914
23,100
59,425
35,358
12,135
7,549
8,576
14,601
16,901
14,308
33,187
50,384
47,152
46,941
60,496
55,112
48,212
39,926
37,946
37,054
33,831
34,917
33,255
47,089
46,828
69,653
0
069,65346,82847,08933,25534,91733,83137,05437,94639,92648,21255,11260,49646,94147,15250,38433,18714,30816,90114,6018,5767,54912,13535,35859,42523,10030,91423,45215,91314,35624,45120,66110,60911,16118,91815,0457,4586,25816,89012,36812,39626,90221,19327,17219,4938,33318,86825,10125,5357,195191191191191191001919,0897158,8316,21906,6634,6983,1253,1253,70903,6523,65202,0572,3452,0322,6822,413
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
99,450
109,452
125,720
153,274
178,727
191,842
198,727
203,251
210,924
214,661
216,730
217,979
220,083
221,562
219,067
225,914
230,533
235,040
237,745
243,384
245,148
251,633
261,846
269,436
273,249
503,493
515,084
538,970
609,147
624,688
679,819
739,384
817,871
817,328
894,136
939,365
985,976
1,045,655
1,093,068
1,137,403
1,174,579
1,193,922
1,198,296
1,210,548
1,237,406
1,256,726
1,259,994
1,310,951
1,364,872
1,386,714
1,386,7141,364,8721,310,9511,259,9941,256,7261,237,4061,210,5481,198,2961,193,9221,174,5791,137,4031,093,0681,045,655985,976939,365894,136817,328817,871739,384679,819624,688609,147538,970515,084503,493273,249269,436261,846251,633245,148243,384237,745235,040230,533225,914219,067221,562220,083217,979216,730214,661210,924203,251198,727191,842178,727153,274125,720109,45299,450000000000000000000000000000
       Property Plant Equipment 
21,315
21,318
21,322
20,745
19,724
0
20,018
20,018
0
17,994
19,740
19,740
14,280
24,052
0
28,697
37,543
40,646
42,103
46,343
41,261
43,496
46,599
62,689
56,563
66,332
68,539
80,369
78,587
93,605
127,170
154,973
167,320
172,130
177,683
186,755
188,474
189,780
191,319
193,907
193,870
190,368
195,413
200,908
202,118
204,042
207,593
208,367
215,157
224,434
229,105
234,418
461,548
469,981
487,384
551,658
563,612
615,156
660,690
723,688
722,310
794,319
827,356
874,106
930,475
968,684
1,007,428
1,034,437
1,053,584
1,058,945
1,062,027
1,080,794
1,083,588
1,081,261
1,126,495
1,174,066
1,193,866
1,193,8661,174,0661,126,4951,081,2611,083,5881,080,7941,062,0271,058,9451,053,5841,034,4371,007,428968,684930,475874,106827,356794,319722,310723,688660,690615,156563,612551,658487,384469,981461,548234,418229,105224,434215,157208,367207,593204,042202,118200,908195,413190,368193,870193,907191,319189,780188,474186,755177,683172,130167,320154,973127,17093,60578,58780,36968,53966,33256,56362,68946,59943,49641,26146,34342,10340,64637,54328,697024,05214,28019,74019,74017,994020,01820,018019,72420,74521,32221,31821,315
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,541
0
0
0
0
0
0
0
0
0
0
0
-10,272
0
-11,042
-11,809
-11,586
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,361
0
0
0
7,921
7,836
7,781
7,559
7,270
7,196
7,553
7,167
6,841
7,144
6,789
6,783
6,739
6,731
6,371
6,129
5,947
5,956
5,9565,9476,1296,3716,7316,7396,7836,7897,1446,8417,1677,5537,1967,2707,5597,7817,8367,9210004,36100000000000000000000-11,586-11,809-11,0420-10,272000000000004,541000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
284
284
284
284
284
284
279
284
284
284
284
284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000002842842842842842792842842842842842840000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
1,411
4,083
0
4,710
4,439
4,639
4,623
4,807
11,178
11,610
12,814
6,799
14,210
6,463
6,615
6,771
17,695
17,912
19,075
9,114
19,822
20,540
20,137
8,691
10,246
10,174
10,303
11,386
11,666
12,319
13,704
14,799
17,091
18,123
19,541
20,699
20,993
21,916
23,121
24,979
25,800
27,765
31,010
28,724
36,806
37,712
39,905
37,947
40,746
44,116
48,000
52,674
55,445
59,754
65,067
69,895
71,084
72,053
74,105
76,578
79,486
82,952
87,399
90,724
92,539
92,53990,72487,39982,95279,48676,57874,10572,05371,08469,89565,06759,75455,44552,67448,00044,11640,74637,94739,90537,71236,80628,72431,01027,76525,80024,97923,12121,91620,99320,69919,54118,12317,09114,79913,70412,31911,66611,38610,30310,17410,2468,69120,13720,54019,8229,11419,07517,91217,6956,7716,6156,46314,2106,79912,81411,61011,1784,8074,6234,6394,4394,71004,0831,411000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,407
13,170
14,203
1,231
20,364
17,499
12,017
18,184
32,400
25,152
17,794
17,813
14,790
9,922
10,757
10,838
11,390
11,621
11,129
11,585
11,956
11,384
11,284
11,755
10,942
10,214
11,284
12,800
11,227
11,264
11,141
79,779
321,904
267,063
141,597
210,630
170,291
67,483
100,513
151,960
146,444
258,245
195,642
269,647
17,016
24,314
86,999
29,828
155,849
208
208155,84929,82886,99924,31417,016269,647195,642258,245146,444151,960100,51367,483170,291210,630141,597267,063321,90479,77911,14111,26411,22712,80011,28410,21410,94211,75511,28411,38411,95611,58511,12911,62111,39010,83810,7579,92214,79017,81317,79425,15232,40018,18412,01717,49920,3641,23114,20313,1708,407000000000000000000000000000
> Total Liabilities 
65,848
70,895
56,772
78,396
80,388
0
109,322
109,322
0
85,264
116,551
116,551
128,074
144,942
0
182,481
154,962
151,458
176,370
204,071
179,348
190,187
198,048
242,912
225,841
217,821
228,316
267,014
270,169
271,434
310,011
322,997
290,153
337,328
365,205
407,969
360,597
375,820
374,394
415,825
387,057
415,259
384,928
439,323
380,492
414,037
415,443
523,425
447,409
479,731
502,068
536,463
729,006
803,903
853,939
936,109
1,053,969
1,008,217
1,172,741
1,183,733
1,237,295
1,117,181
1,224,486
1,334,865
1,415,469
1,425,056
1,478,517
1,624,964
1,689,741
1,657,889
1,806,648
1,904,054
2,007,474
1,975,891
2,037,153
2,142,739
1,929,172
1,929,1722,142,7392,037,1531,975,8912,007,4741,904,0541,806,6481,657,8891,689,7411,624,9641,478,5171,425,0561,415,4691,334,8651,224,4861,117,1811,237,2951,183,7331,172,7411,008,2171,053,969936,109853,939803,903729,006536,463502,068479,731447,409523,425415,443414,037380,492439,323384,928415,259387,057415,825374,394375,820360,597407,969365,205337,328290,153322,997310,011271,434270,169267,014228,316217,821225,841242,912198,048190,187179,348204,071176,370151,458154,962182,4810144,942128,074116,551116,55185,2640109,322109,322080,38878,39656,77270,89565,848
   > Total Current Liabilities 
61,538
67,095
53,967
75,656
78,133
0
98,893
98,893
0
76,880
105,657
105,657
118,002
125,704
0
157,537
130,937
126,714
152,099
179,009
154,194
166,041
173,923
214,172
197,372
183,063
192,332
228,717
221,328
213,458
236,190
250,946
217,386
265,318
296,774
288,565
246,995
267,229
269,560
315,609
292,684
325,485
313,829
370,484
322,348
357,843
369,590
403,768
328,738
383,504
406,217
470,228
495,334
436,204
471,614
501,244
608,726
543,426
677,796
677,724
741,930
596,315
686,724
814,974
869,055
763,016
809,521
1,008,234
1,066,097
1,100,572
1,012,058
1,134,412
1,190,938
1,193,271
1,204,259
1,184,660
940,753
940,7531,184,6601,204,2591,193,2711,190,9381,134,4121,012,0581,100,5721,066,0971,008,234809,521763,016869,055814,974686,724596,315741,930677,724677,796543,426608,726501,244471,614436,204495,334470,228406,217383,504328,738403,768369,590357,843322,348370,484313,829325,485292,684315,609269,560267,229246,995288,565296,774265,318217,386250,946236,190213,458221,328228,717192,332183,063197,372214,172173,923166,041154,194179,009152,099126,714130,937157,5370125,704118,002105,657105,65776,880098,89398,893078,13375,65653,96767,09561,538
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,901
4,372
4,561
5,504
5,390
19,884
55,257
59,306
21,235
30,971
32,380
29,201
20,938
29,005
40,831
37,116
29,495
41,727
56,645
55,576
46,145
32,540
59,932
62,289
79,581
145,003
89,143
94,600
78,251
183,812
226,375
238,848
161,402
164,892
173,856
181,979
189,137
200,497
234,479
246,320
270,488
459,713
452,269
289,869
266,896
311,815
350,294
325,882
292,728
0
0292,728325,882350,294311,815266,896289,869452,269459,713270,488246,320234,479200,497189,137181,979173,856164,892161,402238,848226,375183,81278,25194,60089,143145,00379,58162,28959,93232,54046,14555,57656,64541,72729,49537,11640,83129,00520,93829,20132,38030,97121,23559,30655,25719,8845,3905,5044,5614,3724,901000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,829
91,003
104,578
55,351
46,085
32,486
58,433
60,790
78,082
145,003
22,001
25,770
1,278
103,411
135,214
139,497
53,400
54,377
53,740
55,867
54,532
58,071
88,331
97,870
118,395
302,337
293,671
128,915
102,535
188,887
227,430
170,951
162,925
130,233
130,233162,925170,951227,430188,887102,535128,915293,671302,337118,39597,87088,33158,07154,53255,86753,74054,37753,400139,497135,214103,4111,27825,77022,001145,00378,08260,79058,43332,48646,08555,351104,57891,00388,8290000000000000000000000000000000000000000000
       Accounts payable 
47,672
53,542
40,465
59,641
60,707
0
79,584
79,584
0
56,458
84,021
78,332
87,156
83,231
0
108,290
90,882
78,039
98,331
129,123
105,846
107,697
107,200
151,758
139,732
112,863
111,826
151,475
146,809
134,296
136,844
160,036
116,091
125,684
150,382
184,292
132,734
152,414
145,504
209,763
183,593
190,720
174,200
250,242
189,435
198,386
204,715
262,539
207,416
223,947
228,232
279,772
246,210
243,984
255,117
303,155
321,928
187,828
300,155
371,763
412,075
260,747
335,031
464,714
503,177
348,952
373,646
555,452
456,113
466,801
512,595
679,763
690,036
559,433
624,872
630,823
456,778
456,778630,823624,872559,433690,036679,763512,595466,801456,113555,452373,646348,952503,177464,714335,031260,747412,075371,763300,155187,828321,928303,155255,117243,984246,210279,772228,232223,947207,416262,539204,715198,386189,435250,242174,200190,720183,593209,763145,504152,414132,734184,292150,382125,684116,091160,036136,844134,296146,809151,475111,826112,863139,732151,758107,200107,697105,846129,12398,33178,03990,882108,290083,23187,15678,33284,02156,458079,58479,584060,70759,64140,46553,54247,672
       Other Current Liabilities 
12,833
12,895
12,635
14,428
16,075
0
19,218
19,218
0
19,792
21,444
27,133
30,187
39,956
0
46,647
36,873
45,872
50,501
46,634
44,858
54,778
63,088
58,712
54,250
66,432
76,286
51,942
70,147
74,601
57,792
61,847
58,926
58,972
61,814
58,072
61,810
56,040
62,688
58,406
57,020
63,907
70,186
65,045
65,460
68,235
74,871
68,080
67,520
72,238
79,591
81,824
78,395
84,282
93,695
94,612
77,178
100,207
112,076
114,659
107,549
128,732
134,076
130,322
143,912
136,830
149,918
151,711
122,055
149,025
174,282
185,600
178,867
282,731
204,701
209,330
65,801
65,801209,330204,701282,731178,867185,600174,282149,025122,055151,711149,918136,830143,912130,322134,076128,732107,549114,659112,076100,20777,17894,61293,69584,28278,39581,82479,59172,23867,52068,08074,87168,23565,46065,04570,18663,90757,02058,40662,68856,04061,81058,07261,81458,97258,92661,84757,79274,60170,14751,94276,28666,43254,25058,71263,08854,77844,85846,63450,50145,87236,87346,647039,95630,18727,13321,44419,792019,21819,218016,07514,42812,63512,89512,833
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,297
48,841
57,976
73,821
72,051
72,767
72,010
68,431
119,404
113,602
108,591
104,834
100,216
94,373
89,774
71,099
68,839
58,144
56,194
45,853
119,657
118,671
96,227
95,851
66,235
233,672
367,699
382,325
434,865
445,243
464,791
494,945
506,009
495,365
520,866
537,762
519,891
546,414
662,040
668,996
616,730
623,644
557,317
794,590
769,642
816,536
781,826
832,894
958,079
988,419
988,419958,079832,894781,826816,536769,642794,590557,317623,644616,730668,996662,040546,414519,891537,762520,866495,365506,009494,945464,791445,243434,865382,325367,699233,67266,23595,85196,227118,671119,65745,85356,19458,14468,83971,09989,77494,373100,216104,834108,591113,602119,40468,43172,01072,76772,05173,82157,97648,84138,297000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
375,475
427,152
436,748
453,901
482,248
491,590
474,588
495,973
508,061
501,790
522,883
637,746
652,696
601,052
609,147
546,911
784,796
0
0
0
0
0
0
000000784,796546,911609,147601,052652,696637,746522,883501,790508,061495,973474,588491,590482,248453,901436,748427,152375,475000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,901
-4,372
-4,561
-5,504
-5,390
-19,884
-55,257
-59,306
-21,235
-30,971
-32,380
-29,201
-20,938
-29,005
-40,831
-37,116
-29,495
-41,727
-56,645
-55,576
-46,145
-32,540
-59,932
-62,289
-79,581
27,034
153,639
164,705
240,874
148,337
160,116
184,180
306,047
288,068
336,519
346,480
367,972
385,526
376,558
381,969
366,228
190,381
193,240
345,881
373,256
330,861
289,157
330,651
388,420
695,313
695,313388,420330,651289,157330,861373,256345,881193,240190,381366,228381,969376,558385,526367,972346,480336,519288,068306,047184,180160,116148,337240,874164,705153,63927,034-79,581-62,289-59,932-32,540-46,145-55,576-56,645-41,727-29,495-37,116-40,831-29,005-20,938-29,201-32,380-30,971-21,235-59,306-55,257-19,884-5,390-5,504-4,561-4,372-4,901000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
0
0
0
0
0
0
0
0
0
0
6,579
6,793
6,793
6,665
6,820
6,944
7,087
7,220
7,343
7,459
7,559
7,634
7,694
7,6947,6347,5597,4597,3437,2207,0876,9446,8206,6656,7936,7936,57900000000005400000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
81,945
85,611
88,435
93,622
100,196
100,196
108,191
108,191
108,191
114,352
117,743
117,743
125,387
130,807
130,807
150,600
156,901
164,017
170,791
173,034
181,115
188,367
195,566
199,243
209,028
219,442
228,702
233,640
242,542
255,811
269,723
276,897
283,944
299,103
304,698
311,302
316,841
328,304
334,992
344,142
354,360
363,744
372,042
381,650
395,404
406,203
414,115
426,747
437,887
441,622
452,750
463,912
477,291
481,821
498,578
524,176
534,292
529,635
1,003,628
1,010,640
1,016,164
1,024,745
1,029,346
1,046,195
1,046,361
1,079,578
1,090,998
1,108,162
1,126,826
1,125,846
1,139,057
1,173,416
1,196,824
1,171,580
1,195,566
1,234,714
1,245,825
1,245,8251,234,7141,195,5661,171,5801,196,8241,173,4161,139,0571,125,8461,126,8261,108,1621,090,9981,079,5781,046,3611,046,1951,029,3461,024,7451,016,1641,010,6401,003,628529,635534,292524,176498,578481,821477,291463,912452,750441,622437,887426,747414,115406,203395,404381,650372,042363,744354,360344,142334,992328,304316,841311,302304,698299,103283,944276,897269,723255,811242,542233,640228,702219,442209,028199,243195,566188,367181,115173,034170,791164,017156,901150,600130,807130,807125,387117,743117,743114,352108,191108,191108,191100,196100,19693,62288,43585,61181,945
   Common Stock
78,000
80,000
84,000
87,000
92,000
0
98,500
98,500
0
106,500
106,500
106,500
116,000
124,000
0
129,500
129,500
148,000
148,000
148,000
148,000
170,000
170,000
170,000
170,000
195,000
195,000
195,000
195,000
227,000
227,000
227,000
227,000
260,000
260,000
260,000
260,000
295,000
295,000
295,000
295,000
325,000
325,000
325,000
325,000
360,000
360,000
360,000
360,000
385,000
385,000
385,000
385,000
410,000
410,000
410,000
410,000
410,000
897,839
897,552
912,000
918,000
918,000
903,552
903,552
943,000
943,000
928,552
943,000
970,116
970,116
955,668
955,668
955,668
981,773
981,773
0
0981,773981,773955,668955,668955,668970,116970,116943,000928,552943,000943,000903,552903,552918,000918,000912,000897,552897,839410,000410,000410,000410,000410,000385,000385,000385,000385,000360,000360,000360,000360,000325,000325,000325,000325,000295,000295,000295,000295,000260,000260,000260,000260,000227,000227,000227,000227,000195,000195,000195,000195,000170,000170,000170,000170,000148,000148,000148,000148,000129,500129,5000124,000116,000106,500106,500106,500098,50098,500092,00087,00084,00080,00078,000
   Retained Earnings 
573
4,319
633
673
1,126
0
1,277
1,277
0
7,116
1,469
1,469
1,275
1,216
0
22,251
28,785
16,421
23,327
25,720
33,801
18,117
25,770
29,877
39,851
24,671
33,946
38,916
47,818
28,811
42,903
50,514
7,279
39,720
31,137
52,380
5,539
18,431
25,367
50,468
10,218
22,851
31,149
56,783
70,477
28,731
54,662
67,363
80,013
28,353
70,811
88,320
13,379
21,888
38,645
114,176
14,518
17,923
33,472
129,444
147,657
149,757
159,465
176,052
165,622
181,632
191,876
208,978
227,194
196,137
207,882
240,905
262,855
16,381
231,971
273,683
12,586
12,586273,683231,97116,381262,855240,905207,882196,137227,194208,978191,876181,632165,622176,052159,465149,757147,657129,44433,47217,92314,518114,17638,64521,88813,37988,32070,81128,35380,01367,36354,66228,73170,47756,78331,14922,85110,21850,46825,36718,4315,53952,38031,13739,7207,27950,51442,90328,81147,81838,91633,94624,67139,85129,87725,77018,11733,80125,72023,32716,42128,78522,25101,2161,2751,4691,4697,11601,2771,27701,1266736334,319573
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000-33,4090-28,5640000000000-3,061-6,004-2,126-616-547-114-73-133-133-133-1,326-1,326-1,326-1,078-1,078-1,078-883-617-850-617-1800-276-276-244-229-823-634-480-26-962-962-776-682-1,700-1,5040-234-1,779-400-400-1230-671-6710-872-659-2140-45
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-276
-276
0
-180
-617
49,665
-617
13,561
-1,078
51,302
14,873
14,625
-1,326
49,142
15,893
15,893
-133
-73
17,472
-547
66,747
-2,126
28,269
-3,061
78,912
78,912
0
0
0
109,774
101,712
72,317
-16,967
-29,045
-28,564
-36,094
-36,690
142,809
-34,018
-34,020
-35,139
-35,844
-28,577
-28,582
-28,582
-28,582
-24,050
-19,064
-23,993
0
0-23,993-19,064-24,050-28,582-28,582-28,582-28,577-35,844-35,139-34,020-34,018142,809-36,690-36,094-28,564-29,045-16,96772,317101,712109,77400078,91278,912-3,06128,269-2,12666,747-54717,472-73-13315,89315,89349,142-1,32614,62514,87351,302-1,07813,561-61749,665-617-1800-276-276000000000000000000000000000



6.3. Balance Sheets

Currency in BRL. All numbers in thousands.




6.4. Cash Flows

Currency in BRL. All numbers in thousands.




6.5. Income Statements

Currency in BRL. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in BRL. All numbers in thousands.

Gross Profit (+$)
totalRevenue4,942,462
Cost of Revenue-3,371,196
Gross Profit1,571,2661,571,266
 
Operating Income (+$)
Gross Profit1,571,266
Operating Expense-1,375,987
Operating Income195,279195,279
 
Operating Expense (+$)
Research Development0
Selling General Administrative28,358
Selling And Marketing Expenses260,471
Operating Expense1,375,987288,829
 
Net Interest Income (+$)
Interest Income6,181
Interest Expense-113,967
Other Finance Cost-2,339
Net Interest Income-110,125
 
Pretax Income (+$)
Operating Income195,279
Net Interest Income-110,125
Other Non-Operating Income Expenses0
Income Before Tax (EBT)112,564277,994
EBIT - interestExpense = 112,564
112,564
219,476
Interest Expense113,967
Earnings Before Interest and Taxes (EBIT)226,531226,531
Earnings Before Interest and Taxes (EBITDA)436,734
 
After tax Income (+$)
Income Before Tax112,564
Tax Provision-7,055
Net Income From Continuing Ops105,509105,509
Net Income105,509
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,747,183
Total Other Income/Expenses Net-82,715110,125
 

Technical Analysis of Dimed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dimed. The general trend of Dimed is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dimed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Dimed Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dimed S.A. Distribuidora de Medicamentos.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 10.02 < 10.08 < 10.35.

The bearish price targets are: 9.5686542094456 > 9.1132 > 8.9844.

Know someone who trades $PNVL3? Share this with them.πŸ‘‡

Dimed S.A. Distribuidora de Medicamentos Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dimed S.A. Distribuidora de Medicamentos. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dimed S.A. Distribuidora de Medicamentos Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dimed S.A. Distribuidora de Medicamentos. The current macd is 0.26160558.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dimed price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Dimed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Dimed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dimed S.A. Distribuidora de Medicamentos Daily Moving Average Convergence/Divergence (MACD) ChartDimed S.A. Distribuidora de Medicamentos Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dimed S.A. Distribuidora de Medicamentos. The current adx is 34.94.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Dimed shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Dimed S.A. Distribuidora de Medicamentos Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dimed S.A. Distribuidora de Medicamentos. The current sar is 9.1044773.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Dimed S.A. Distribuidora de Medicamentos Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dimed S.A. Distribuidora de Medicamentos. The current rsi is 66.52. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Dimed S.A. Distribuidora de Medicamentos Daily Relative Strength Index (RSI) ChartDimed S.A. Distribuidora de Medicamentos Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dimed S.A. Distribuidora de Medicamentos. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dimed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Dimed S.A. Distribuidora de Medicamentos Daily Stochastic Oscillator ChartDimed S.A. Distribuidora de Medicamentos Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dimed S.A. Distribuidora de Medicamentos. The current cci is 79.58.

Dimed S.A. Distribuidora de Medicamentos Daily Commodity Channel Index (CCI) ChartDimed S.A. Distribuidora de Medicamentos Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dimed S.A. Distribuidora de Medicamentos. The current cmo is 37.61.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Dimed S.A. Distribuidora de Medicamentos Daily Chande Momentum Oscillator (CMO) ChartDimed S.A. Distribuidora de Medicamentos Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dimed S.A. Distribuidora de Medicamentos. The current willr is -11.46496815.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Dimed S.A. Distribuidora de Medicamentos Daily Williams %R ChartDimed S.A. Distribuidora de Medicamentos Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Dimed S.A. Distribuidora de Medicamentos.

Dimed S.A. Distribuidora de Medicamentos Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dimed S.A. Distribuidora de Medicamentos. The current atr is 0.27681047.

Dimed S.A. Distribuidora de Medicamentos Daily Average True Range (ATR) ChartDimed S.A. Distribuidora de Medicamentos Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dimed S.A. Distribuidora de Medicamentos. The current obv is -5,927,100.

Dimed S.A. Distribuidora de Medicamentos Daily On-Balance Volume (OBV) ChartDimed S.A. Distribuidora de Medicamentos Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dimed S.A. Distribuidora de Medicamentos. The current mfi is 83.96.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Dimed S.A. Distribuidora de Medicamentos Daily Money Flow Index (MFI) ChartDimed S.A. Distribuidora de Medicamentos Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dimed S.A. Distribuidora de Medicamentos.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Dimed S.A. Distribuidora de Medicamentos Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dimed S.A. Distribuidora de Medicamentos based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.521
Ma 20Greater thanMa 508.944
Ma 50Greater thanMa 1008.919
Ma 100Greater thanMa 2008.646
OpenGreater thanClose9.600
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Dimed with someone you think should read this too:
  • Are you bullish or bearish on Dimed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dimed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dimed S.A. Distribuidora de Medicamentos

I send you an email if I find something interesting about Dimed S.A. Distribuidora de Medicamentos.


Comments

How you think about this?

Leave a comment

Stay informed about Dimed S.A. Distribuidora de Medicamentos.

Receive notifications about Dimed S.A. Distribuidora de Medicamentos in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.